CB1R AS A POTENTIAL THERAPEUTIC TARGET IN CRBN DEFICIENCY-ASSOCIATED MENTAL RETARDATION
Hoofdauteurs: | Alba Hermoso-López, Carlos Costas-Insua, Carlos Montero-Fernández, Estefanía Moreno, Alicia Álvaro-Blázquez, David Martín-Gutiérrez, Irene B. Maroto-Martínez, Rebeca Diez-Alarcia, Leyre Urigüen, Vicent Casadó, Ignacio Rodríguez-Crespo, Manuel Guzmán |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Elsevier
2023-10-01
|
Reeks: | IBRO Neuroscience Reports |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S2667242123018250 |
Gelijkaardige items
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
door: Carlos Costas-Insua, et al.
Gepubliceerd in: (2024-03-01) -
Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
door: Seung-Joo Yang, et al.
Gepubliceerd in: (2021-05-01) -
DISCOVERING THE MOLECULAR MECHANISMS UNDERLYING CANNABIS-INDUCED INCREASED RISK OF SCHIZOPHRENIA: EVALUATION OF THE AKT/MTOR/S6 PATHWAY STATUS IN A DOUBLE HIT RODENT MODEL.
door: Silvia Iñiguez-Barrio, et al.
Gepubliceerd in: (2023-10-01) -
The Relationship Between the Expression of CRBN in Peripheral Blood and the Severity and Prognosis of Adult Sepsis
door: Kuang Z, et al.
Gepubliceerd in: (2023-11-01) -
Proximity-driven degrader development: insights from CRBN and a validated neo-substrate
door: Song, J
Gepubliceerd in: (2024)